Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety.
Basso AM, Bratcher NA, Gallagher KB, Cowart MD, Zhao C, Sun M, Esbenshade TA, Brune ME, Fox GB, Schmidt M, Collins CA, Souers AJ, Iyengar R, Vasudevan A, Kym PR, Hancock AA, Rueter LE. Basso AM, et al. Among authors: esbenshade ta. Eur J Pharmacol. 2006 Jul 1;540(1-3):115-20. doi: 10.1016/j.ejphar.2006.04.043. Epub 2006 May 6. Eur J Pharmacol. 2006. PMID: 16765941
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE. Zhang M, et al. Among authors: esbenshade ta. Brain Res. 2005 May 31;1045(1-2):142-9. doi: 10.1016/j.brainres.2005.03.018. Epub 2005 Apr 20. Brain Res. 2005. PMID: 15910772
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model.
Fox GB, Pan JB, Esbenshade TA, Bitner RS, Nikkel AL, Miller T, Kang CH, Bennani YL, Black LA, Faghih R, Hancock AA, Decker MW. Fox GB, et al. Among authors: esbenshade ta. Pharmacol Biochem Behav. 2002 Jun;72(3):741-50. doi: 10.1016/s0091-3057(02)00745-1. Pharmacol Biochem Behav. 2002. PMID: 12175472
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.
Fox GB, Pan JB, Radek RJ, Lewis AM, Bitner RS, Esbenshade TA, Faghih R, Bennani YL, Williams M, Yao BB, Decker MW, Hancock AA. Fox GB, et al. Among authors: esbenshade ta. J Pharmacol Exp Ther. 2003 Jun;305(3):897-908. doi: 10.1124/jpet.102.047241. Epub 2003 Feb 20. J Pharmacol Exp Ther. 2003. PMID: 12606600
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.
Gfesser GA, Zhang H, Dinges J, Fox GB, Pan JB, Esbenshade TA, Yao BB, Witte D, Miller TR, Kang CH, Krueger KM, Bennani YL, Hancock AA, Faghih R. Gfesser GA, et al. Among authors: esbenshade ta. Bioorg Med Chem Lett. 2004 Feb 9;14(3):673-6. doi: 10.1016/j.bmcl.2003.11.038. Bioorg Med Chem Lett. 2004. PMID: 14741266
102 results